Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review)

12Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

Abstract

Metastasis is one of the major reasons for patient mortality in hepatocellular carcinoma (HCC), and the progression of HCC to a metastatic state depends on the local microenvironment. Hypoxia is a key condition affecting the microenvironment of HCC. Currently, various studies have shown that the expression of hypoxia‑ainducible factor‑1α (HIF‑1α) is associated with the invasion and metastasis of HCC. High expression of HIF‑1α often leads to poor prognosis in patients with HCC. In this review, the molecular structure of HIF‑1α is described, and the expression pattern of HIF‑1α in HCC under hypoxia, which is associated with metastasis and poor prognosis in HCC, is explained. The molecular mechanisms of HIF‑1α function and the metastasis of HCC are further discussed. The modulation of HIF‑1α can reduce sorafenib resistance and improve the prognosis of patients after TACE. Therefore, HIF‑1α may be a critical target for inhibiting HCC metastasis in the future.

Cite

CITATION STYLE

APA

Chen, H., Chen, J., Yuan, H., Li, X., & Li, W. (2022, August 1). Hypoxia‑inducible factor‑1α: A critical target for inhibiting the metastasis of hepatocellular carcinoma (Review). Oncology Letters. Spandidos Publications. https://doi.org/10.3892/ol.2022.13404

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free